| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
1 Department of Oncology, Second Affiliated Hospital, and 2 Cancer Institute, College of Medicine, Zhejiang University, HangZhou, Zhejiang, Peoples Republic of China
Purpose: The low specificity and sensitivity of the carcinoembryonic antigen test makes it not an ideal biomarker for the detection of colorectal cancer. We developed and evaluated a proteomic approach for the simultaneous detection and analysis of multiple proteins for distinguishing individuals with colorectal cancer from healthy individuals.
Experimental Design: We subjected serum samples (including 55 colorectal cancer patients and 92 age- and sex-matched healthy individuals) from 147 individuals, for analysis by surface-enhanced laser desorption/ionization (SELDI) mass spectrometry. Peaks were detected with Ciphergen SELDI software version 3.0. Using a multilayer artificial neural network with a back propagation algorithm, we developed a classifier for separating the colorectal cancer groups from the healthy groups.
Results: The artificial neural network classifier separated the colorectal cancer from the healthy samples, with a sensitivity of 91% and specificity of 93%. Four top-scored peaks, at m/z of 5,911, 8,930, 8,817, and 4,476, were finally selected as the potential "fingerprints" for detection of colorectal cancer.
Conclusions: The combination of SELDI-TOF mass spectrometry with the artificial neural networks in the analysis of serum protein yields significantly higher sensitivity and specificity values for the detection and diagnosis of colorectal cancer.
This article has been cited by other articles:
![]() |
A. LEBRECHT, D. BOEHM, M. SCHMIDT, H. KOELBL, R. L. SCHWIRZ, and F. H. GRUS Diagnosis of Breast Cancer by Tear Proteomic Pattern Cancer Genomics Proteomics, May 1, 2009; 6(3): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Lancashire, C. Lemetre, and G. R. Ball An introduction to artificial neural networks in bioinformatics--application to complex microarray and mass spectrometry datasets in cancer studies Brief Bioinform, May 1, 2009; 10(3): 315 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. LEBRECHT, D. BOEHM, M. SCHMIDT, H. KOELBL, and F. H. GRUS Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum Cancer Genomics Proteomics, March 1, 2009; 6(2): 75 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Ransohoff, C. Martin, W. S. Wiggins, B. A. Hitt, T. O. Keku, J. A. Galanko, and R. S. Sandler Assessment of Serum Proteomics to Detect Large Colon Adenomas Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2188 - 2193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hundt, U. Haug, and H. Brenner Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1935 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-x. Wang, P. Qin, Q.-l. Liu, H.-y. Yang, Y.-z. Fan, J.-k. Yu, and S. Zheng Detection and Significance of Serum Protein Marker of Hirschsprung Disease Pediatrics, July 1, 2007; 120(1): e56 - e60. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nedelkov, U. A. Kiernan, E. E. Niederkofler, K. A. Tubbs, and R. W. Nelson Population Proteomics: The Concept, Attributes, and Potential for Cancer Biomarker Research Mol. Cell. Proteomics, October 1, 2006; 5(10): 1811 - 1818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |